Platinum(II) terpyridine complexes with glycosylated acetylide and arylacetylide ligands bind to DNA with binding constants approximately 10(5) mol(-1) dm(3); the glycosylated arylacetylide complexes exhibit emission at lambda(max) approximately 620 nm in water and are up to approximately 100-times higher in potency than the clinical cisplatin drug in killing cancer cells.

A template-directed synthetic approach to halogen-bridged mixed-valence platinum complexes has been performed in organic media using, for instance, a synthetic peptide bearing two bis(ethylenediamine)-based Pt(IV) complexes with two axial bromide anionic ligands, [(Pt(IV)Br2(en))2](RSO3)4, and a [Pt(II)(en)2](RSO3)2 complex (R = (C12H25OCH2)2CHO(CH2)3-).

Glucose-conjugated malonato-platinum(II) complexes are designed and synthesized to target tumor-specific active transporters, namely, glucose transporters (GLUTs); the complexes exhibit much higher aqueous solubility by 150 times, improved potency in cytotoxicities by 10 times, and increased therapeutic index by over 30 fold compared to the newest generation of clinical drugs oxaliplatin.

Isomeric complexes of platinum, which contain two non-innocent ligands are reported. The built-in coordination asymmetry in the ligands makes it possible to separate two different positional isomers. Results from X-ray crystallography is used to invoke the popular structure oxidation state correlation in these complexes. The redox processes are discussed and interpreted with the help of UV-vis-...

Oxidation of a doubly cyclometallated platinum(II) complex results in two isomeric platinum(IV) complexes. Whereas the trans isomer is robust, being manipulable in air at room temperature, the cis isomer decomposes at -20 °C and above. Reductive coupling of an alkyl chloride at the cis isomer gives a new species which can be reoxidised. The independence of this coupling on additional halide rul...

Five dinuclear platinum(II) complexes with a novel chiral ligand, 2-(((1R,2R)-2-aminocyclohexylamino)methyl)phenol (HL), were designed, prepared and spectrally characterized. In vitro cytotoxicity of all the resulting platinum(II) compounds was evaluated against human HEPG-2, A549 and HCT-116 cell lines, respectively. Results indicated that all compounds showed positive biological activity. Par...

The electronic structure of model platinum-guanine and tin-guanine adducts has been studied both at semiempirical level and by using ab initio methods at the correlation level. The possible binding energies have been evaluated and most probable strustures were determined. In all cases the binding enegies of the gaseous tin chelates are rather large. The stabilizing role of the hydrogen bonds ha...

Certain complexes of the platinum group metals exhibit interesting biological efects. At low concentrations some are efective baeteriocides; others stop cell division and force bacteria to grow into long filaments. These complexes can also induce destruction of lysogenic bacteria. Most important, perhaps, some of these complexes are very potent anti-tumour agents against a broad spectrum of tum...

Understanding the interactions between metal complexes and oxide surfaces is crucial to the synthesis of supported metal catalysts. Recently developed in situ techniques have made it possible to closely characterize the solid/liquid interface. For the first time, the adsorption of platinum complexes on alumina and silica has been probed using a quartz crystal microbalance; we were able to obser...

Reaction of tetraphosphine platinum(II) complexes with 2-azidoethyl isocyanide 3 in methanol leads to complexes with two trans-coordinated NH,NH-stabilized carbene ligands 6(X)(2). Complexes 6(X)(2) react with phenyldivinylphosphine under substitution of the remaining phosphine ligands followed by an intramolecular hydroamination reaction to produce complex 1(PF(6))(2) with a macrocyclic [16]an...